No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 1.6x · 10Y median 2.0x · 36th percentile · as of Oct 6, 2026
Annualized revenue (TTM) · by quarter, last 20
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T15:05:32.389Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T15:05:32.389Z. Latest historical point 2023-08-14.
EV/EBITDA and cash-flow multiples are withheld until their applicability to this financial-services business is verified. The lenses that apply are shown above; see also P/B and ROE.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T15:05:32.389Z. Latest historical point 2023-08-14.
EBITDA and cash-flow yields are withheld until their applicability to this financial-services business is verified. Earnings yield is shown above; see also P/B and ROE.
The latest delayed quote for AlTi Global, Inc. (ALTI) stock was $2.99 as of Oct 6, 2026, 11:05 AM EDT, up 1.19% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -19.3% · 3-year avg -23.9%/yr · 5-year avg -21.4%/yr
AlTi Global, Inc., a New York-headquartered financial services firm, delivers comprehensive wealth and asset management solutions to a global clientele, including individuals, families, foundations, and institutions. The company provides a broad spectrum of services, ranging from discretionary and non-discretionary investment management to specialized trust and administration offerings.
Asset Management - Global · New York City, NY
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2024-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2024-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Next Earnings Date
Nov 11, 2026
36 days away
EPS Estimate
0.02
Revenue Est.
$65.80M
Last Quarter Results
EPS
$0.00
vs Estimate
$0.06
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1ALTI | $443.25M | $2.98 | +1.19% | -19.32% | -21.43% | N/A | N/A |
| 2PBFS | $442.86M | $17.66 | +1.67% | +32.32% | +6.35% | N/A | vs ALTI |
| 3AMSF | $441.60M | $23.61 | +1.42% | -41.47% | -9.78% | -2.95% | vs ALTI |
| 4BMRC | $445.62M | $27.52 | +0.38% | +19.37% | -2.35% | +4.09% | vs ALTI |
| 5IACO | $437.94M | $10.01 | +0.10% | N/A | N/A | N/A | vs ALTI |
| 6CXII | $448.81M | $10.75 | N/A | N/A | N/A | N/A | vs ALTI |
forward FY estimate
22.96
$58.00M
vs Estimate
$61.80M
Consensus Rating
Based on 1 analyst
Average Price Target
$9.00
+201.5% upside
Low
$9.00
Current
$2.98
High
$9.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $0.02 | $0.02 | $0.02 | 1 |
| Quarter ending Dec 2026 | $0.04 | $0.04 | $0.04 | 1 |
| Quarter ending Mar 2027 | $0.09 | $0.09 | $0.09 | 1 |
| Quarter ending Jun 2027 | $0.09 | $0.09 | $0.09 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $0.13 | $0.13 | $0.13 | 1 |
| FY 2027 | $0.40 | $0.40 | $0.40 | 1 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $65.80M | $65.80M | $65.80M | 1 |
| Quarter ending Dec 2026 | $102.30M | $102.30M | $102.30M | 1 |
| Quarter ending Mar 2027 | $69.10M | $69.10M | $69.10M | 1 |
| Quarter ending Jun 2027 | $70.80M | $70.80M | $70.80M | 1 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E uses the consensus EPS estimate for the fiscal year ending Dec 31, 2026, matching Key Metrics.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $299.30M | $299.30M | $299.30M | 1 |
| FY 2027 | $326.80M | $326.80M | $326.80M | 1 |
